Clinical trial
Circulating Metabolites and Tumor-derived Extravesicular Proteins in Small Cell Lung Cancer
NCT05623956 is registered in ClinicalTrials.gov with Aalborg University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Circulating Metabolites and Tumor-derived Extravesicular Proteins in Small Cell Lung Cancer
- Lead sponsor
- Aalborg University Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 1, 2023
- Completion date
- December 31, 2025
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
small cell lung cancer